CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$3.91
-0.01 (-0.26%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+456.8% upside
Low Target
$14.42
Average Target
$21.77
High Target
$30.48
Current Price
$3.91
Current
$3.91
$3.91
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Scenario Analysis
Bear Case
$14.42
268.8%
Low target
Base Case
$21.77
+456.8%
Avg target
Bull Case
$30.48
+679.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$8.48
-53.9% from high
52-Week Low
$1.03
+280.9% from low
Target vs 52W High
$21.77
+156.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +2.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.5% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -15.1% |
| REGN | Buy | 37 | 70% | $76.80 | -90.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -54.0% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.5% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.6% |